NovelStem International Corp. (NSTM)
NovelStem International Corp. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Boca Raton, FL, US. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $493,325. On trailing twelve-month figures it carries a trailing P/E of -1.54, a net margin of 0.0%. Its beta of 2.47 implies it has historically moved more than the broad market.
NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.
NovelStem International Corp. is most often compared with the following Healthcare names: